Sjogren's Syndrome Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials

Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren's Syndrome Phase Ib-IIa Placebo-Controlled Clinical Trial and Associated Mechanistic Studies
Condition:   Sjogren's Syndrome Interventions:   Drug: tofacitinib;   Other: Placebo Sponsor:   National Institute of Dental and Craniofacial Research (NIDCR) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 4, 2020 Category: Research Source Type: clinical trials

Oral Pilocarpine in the Treatment of the Dry Eye of Patients With Sjogrens Syndrome
Condition:   Dry Eye Interventions:   Drug: Pilocarpine Hydrochloride;   Drug: Placebo Sponsor:   Federal University of São Paulo Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2020 Category: Research Source Type: clinical trials